[Cell Culture Supplement] nLiven PR™
Pathogen-reduced Human Platelet Lysate GMP Compliant
PATHOGEN-REDUCED HUMAN PLATELET LYSATE
Vital to Clinical Progress
nLiven PRTM is a human platelet lysate (HPL) using a unique pathogen-reduction process that is GMP compliant. It is designed to meet your needs for the evolving global regulations and challenging development milestones.
nLiven PR™ Ordering Information
|nLiven PR 100mL||PL-PR-100|
|nLiven PR 500mL||PL-PR-500|
nLiven PR is your tool to develop therapeutics by providing:
- Safety: validated pathogen reduction in an ISO 9001 certified facility and tested for sterility, mycoplasma, and endotoxin
- Reproducibility: minimized lot-to-lot variability by pooling over 100 human U.S. donors from AABB accredited/FDA registered blood centers
- Reliability: established manufacturer, dependable supply to meet your large-scale commercialization needs, and stable pricing
- Compliance: produced under consideration of European Pharmacopoeia General Chapter 220.127.116.11
nLiven PR, vital to clinical progress.